National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Efficient Funding of Chemotherapy) Special Arrangement 2024.
(1) This section applies in relation to a chemotherapy prescription that is not a medication chart prescription. (2) The prescription must include the following information: (a) the name of the chemotherapy drug directed to be supplied; (b) the dose of the drug directed to be supplied; (c) if supply of the dose of the drug is to be repeated—the number of times it is to be repeated. (3) The following provisions of the Regulations do not apply in relation to the writing of the prescription: (a) paragraph 40(1)(d) and subsection 40(2A); (b) paragraph 40(1)(e); (c) paragraph 40(1)(j) and section 49; (d) paragraph 40(3)(a).
Note: If the prescription includes directions about particular pharmaceutical benefits to be supplied, an approved supplier is not required to follow the prescriber’s directions—see subsection 23(8).